Article Details

IMIC Medical Research Center Adds New Agents to ACTIV-2 Clinical Trial in Miami Dade to ...

Retrieved on: 2021-03-08 09:00:00

Tags for this article:

Click the tags to see associated articles and topics

IMIC Medical Research Center Adds New Agents to ACTIV-2 Clinical Trial in Miami Dade to .... View article details on hiswai:

Excerpt

Also available treatment with Astra Zeneca monoclonal antibodies AZD7442 (IV) or (IM), which is a combination of 2 human monoclonal antibodies, or ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo